Full text

Turn on search term navigation

© Heideman et al.; licensee BioMed Central Ltd. 2012. This work is published under http://creativecommons.org/licenses/by/2.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Background

Prevalence of type 2 diabetes mellitus is increasing due to lifestyle changes, particularly affecting those genetically at risk. We developed DiAlert as a targeted group-based intervention aimed to promote intrinsic motivation and action planning for lifestyle changes and weight loss in first degree relatives of patients with type 2 diabetes mellitus.

The main objective of the pilot of the DiAlert intervention was to assess fidelity, feasibility and acceptability prior to starting the randomized controlled trial.

Methods

Individuals with a family history of type 2 diabetes mellitus were self-identified and screened for eligibility. DiAlert consists of two group sessions. Feasibility, fidelity, acceptability and self-reported perceptions and behavioral determinants were evaluated in a pre-post study using questionnaires and observations. Determinants of behavior change were analyzed using paired-samples t tests and Wilcoxon signed rank tests.

Results

DiAlert was delivered to two groups of first degree relatives of patients with type 2 diabetes mellitus (N = 9 and N = 12). Feasibility and fidelity were confirmed. Overall, the DiAlert group sessions were positively evaluated (8.0 on a scale of 1 to 10) by participants. The intervention did not impact perceived susceptibility or worry about personal diabetes risk. Action planning with regard to changing diet and physical activity increased.

Conclusions

DiAlert proved feasible and was well-accepted by participants. Positive trends in action planning indicate increased likelihood of actual behavior change following DiAlert. Testing the effectiveness in a randomized controlled trial is imperative.

Trial registration

Netherlands National Trial Register (NTR): NTR2036

Details

Title
DiAlert: a prevention program for overweight first degree relatives of type 2 diabetes patients: results of a pilot study to test feasibility and acceptability
Author
Heideman, Wieke H 1 ; de Wit, Maartje 1 ; Middelkoop, Barend JC 2 ; Nierkens, Vera 3 ; Stronks, Karien 3 ; Verhoeff, Arnoud P 4 ; Snoek, Frank J 1 

 The EMGO Institute for Health and Care Research, VU University Medical Center, Department of Medical Psychology, Amsterdam, The Netherlands (GRID:grid.466632.3) (ISNI:0000000106863219) 
 Leiden University Medical Centre, Department of Public Health and Primary Care, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000000089452978) 
 Academic Medical Centre, University of Amsterdam, Department of Public Health, Amsterdam, The Netherlands (GRID:grid.5650.6) (ISNI:0000000404654431) 
 Documentation and Health Promotion, Amsterdam Municipal Health Service, Department of Epidemiology, Amsterdam, The Netherlands (GRID:grid.416278.e); University of Amsterdam, Department of Sociology and Anthropology, Amsterdam, The Netherlands (GRID:grid.7177.6) (ISNI:0000000084992262) 
Pages
178
Publication year
2012
Publication date
Dec 2012
Publisher
BioMed Central
e-ISSN
17456215
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2794939579
Copyright
© Heideman et al.; licensee BioMed Central Ltd. 2012. This work is published under http://creativecommons.org/licenses/by/2.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.